<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37263366</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1090-2139</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Brain, behavior, and immunity</Title><ISOAbbreviation>Brain Behav Immun</ISOAbbreviation></Journal><ArticleTitle>Risks of neurological and psychiatric sequelae 2&#xa0;years after hospitalisation or intensive care admission with COVID-19 compared to admissions for other causes.</ArticleTitle><Pagination><StartPage>85</StartPage><EndPage>95</EndPage><MedlinePgn>85-95</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbi.2023.05.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0889-1591(23)00132-0</ELocationID><Abstract><AbstractText>The association between COVID-19 and subsequent neurological and psychiatric disorders is well established. However, two important questions remain unanswered. First, what are the risks in those admitted to intensive care unit (ICU) with COVID-19? Admission to ICU is itself associated with neurological and psychiatric sequelae and it is not clear whether COVID-19 further increases those risks or changes their profile. Second, what are the trajectories of neurological and psychiatric risks in patients admitted to hospital or ICU with COVID-19, and when do the risks subside? We sought to answer these two questions using a retrospective cohort study based on electronic health records (EHR) data from the TriNetX Analytics Network (covering 89 million patients, mostly in the USA). Cohorts of patients admitted to hospital or ICU with COVID-19 were propensity score-matched (for 82 covariates capturing risk factors for COVID-19 and more severe COVID-19 illness) to patients admitted to hospital or ICU (respectively) for any other reason. Matched cohorts were followed for up to two years and the risk of 14 neurological and psychiatric outcomes were compared. A total of 280,173 patients admitted to hospital and 46,573 patients admitted to ICU with COVID-19 were successfully matched to an equal number of patients admitted to hospital or ICU for any other reason. Those hospitalised with COVID-19 were found to be at a greater risk of a range of neurological and psychiatric outcomes including seizure/epilepsy, encephalitis, myoneural junction/muscle disease, Guillain-Barr&#xe9; syndrome (GBS), dementia, cognitive deficits, psychotic disorder, mood and anxiety disorders, but not ischaemic stroke or intracranial haemorrhage. When risks were elevated after COVID-19, most remained so for the whole two years of follow-up (except for mood and anxiety disorders). Risk profiles and trajectories were substantially different among those admitted to ICU: compared to those admitted for any other reasons, those admitted with COVID-19 were at a greater risk of myoneural junction/muscle disease, GBS, cognitive deficits and anxiety disorder, but at a significantly lower risk of ischaemic stroke, intracranial haemorrhage, encephalitis, and mood disorder. When elevated, the risks in those admitted to ICU with COVID-19 were mostly short-lived. In summary, risks of neurological and psychiatric sequelae in patients hospitalised with COVID-19 are wide ranging and long standing whereas those in patients admitted to ICU with COVID-19 are similar to, or lower than, the risks observed post-ICU admission for any other cause. These contrasting risk trajectories are relevant for researchers, clinicians, patients, and policymakers.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ley</LastName><ForeName>Harriet</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Medical Sciences Division, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skorniewska</LastName><ForeName>Zuzanna</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taquet</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Oxford, UK; Oxford Health NHS Foundation Trust, Oxford, UK. Electronic address: maxime.taquet@psych.ox.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NIHR203316</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Brain Behav Immun</MedlineTA><NlmUniqueID>8800478</NlmUniqueID><ISSNLinking>0889-1591</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002545" MajorTopicYN="Y">Brain Ischemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="Y">Stroke</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004660" MajorTopicYN="Y">Encephalitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020300" MajorTopicYN="N">Intracranial Hemorrhages</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electronic health records</Keyword><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">Neuropsychiatric</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>2</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>1</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37263366</ArticleId><ArticleId IdType="pmc">PMC10228171</ArticleId><ArticleId IdType="doi">10.1016/j.bbi.2023.05.014</ArticleId><ArticleId IdType="pii">S0889-1591(23)00132-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abel K.M., Carr M.J., Ashcroft D.M., Chalder T., Chew-Graham C.A., Hope H., Kapur N., McManus S., Steeg S., Webb R.T., Pierce M. Association of SARS-CoV-2 infection with psychological distress, psychotropic prescribing, fatigue, and sleep problems among UK primary care patients. JAMA Netw. Open. 2021;4(11):e2134803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8596199</ArticleId><ArticleId IdType="pubmed">34783824</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28(7):1461&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Birkmeyer J.D., Barnato A., Birkmeyer N., Bessler R., Skinner J. The impact of the COVID-19 pandemic on hospital admissions in the United States. Health Aff. (Millwood) 2020;39(11):2010&#x2013;2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769002</ArticleId><ArticleId IdType="pubmed">32970495</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodilsen J., Nielsen P.B., S&#xf8;gaard M., Dalager-Pedersen M., Speiser L.O.Z., Yndigegn T., Nielsen H., Larsen T.B., Skj&#xf8;th F. Hospital admission and mortality rates for non-covid diseases in Denmark during covid-19 pandemic: nationwide population based cohort study. BMJ. 2021;373</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142604</ArticleId><ArticleId IdType="pubmed">34035000</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift A.K., Ranger T.A., Patone M., Coupland C.A.C., Hatch R., Thomas K., Hippisley-Cox J., Watkinson P. Neuropsychiatric ramifications of severe COVID-19 and other severe acute respiratory infections. JAMA Psychiatry. 2022;79:690&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9096686</ArticleId><ArticleId IdType="pubmed">35544272</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Samranvedhya J., Lipsitch M., Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>De Picker L.J., Leboyer M., Geddes J.R., Morrens M., Harrison P.J., Taquet M. Association between serum lithium level and incidence of COVID-19 infection. Br. J. Psychiatry. 2022;221(1):425&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612897</ArticleId><ArticleId IdType="pubmed">35318909</ArticleId></ArticleIdList></Reference><Reference><Citation>Freedman L.S. Tables of the number of patients required in clinical trials using the logrank test. Stat. Med. 1982;1(2):121&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">7187087</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison P.J., Taquet M. Neuropsychiatric disorders following SARS-CoV-2 infection. Brain. 2023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10232232</ArticleId><ArticleId IdType="pubmed">36729559</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatch R., Young D., Barber V., Griffiths J., Harrison D.A., Watkinson P. Anxiety, depression and Post Traumatic stress disorder after critical illness: a UK-wide prospective cohort study. Crit. Care. 2018;22:310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251214</ArticleId><ArticleId IdType="pubmed">30466485</ArticleId></ArticleIdList></Reference><Reference><Citation>Haukoos J.S., Lewis R.J. The propensity score. JAMA. 2015;314:1637&#x2013;1638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4866501</ArticleId><ArticleId IdType="pubmed">26501539</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenze E.J., Mattar C., Zorumski C.F., Stevens A., Schweiger J., Nicol G.E., Miller J.P., Yang L., Yingling M., Avidan M.S., Reiersen A.M. Fluvoxamine vs Placebo and clinical deterioration in outpatients with symptomatic COVID-19: a randomized clinical trial. JAMA. 2020;324:2292&#x2013;2300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7662481</ArticleId><ArticleId IdType="pubmed">33180097</ArticleId></ArticleIdList></Reference><Reference><Citation>Leys D., H&#xe9;non H., Mackowiak-Cordoliani M.-A., Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4(11):752&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pubmed">16239182</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund L.C., Hallas J., Nielsen H., Koch A., Mogensen S.H., Brun N.C., Christiansen C.F., Thomsen R.W., Potteg&#xe5;rd A. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect. Dis. 2021;21(10):1373&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Most Frequent Principal Diagnoses for Inpatient Stays in US Hospitals, 2018. , in: Statistical Brief# 277.</Citation><ArticleIdList><ArticleId IdType="pubmed">34428003</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham, E.J., Ren, A.L., Digby, R.J., Norton, E.J., Ebrahimi, S., Outtrim, J.G., Chatfield, D.A., Manktelow, A.E., Leibowitz, M.M., Newcombe, V.F.J., Doffinger, R., Barcenas-Morales, G., Fonseca, C., Taussig, M.J., Burnstein, R.M., Samanta, R.J., Dunai, C., Sithole, N., Ashton, N.J., Zetterberg, H., Gissl&#xe9;n, M., Ed&#xe9;n, A., Marklund, E., Openshaw, P.J.M., Dunning, J., Griffiths, M.J., Cavanagh, J., Breen, G., Irani, S.R., Elmer, A., Kingston, N., Summers, C., Bradley, J.R., Taams, L.S., Michael, B.D., Bullmore, E.T., Smith, K.G.C., Lyons, P.A., Coles, A.J., Menon, D.K., Cambridge NeuroCOVID Group, CITIID-NIHR COVID-19 BioResource Collaboration, Cambridge NIHR Clinical Research Facility, 2022. Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses. Brain 145, 4097&#x2013;4107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494359</ArticleId><ArticleId IdType="pubmed">36065116</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V., Fonsmark L., Christensen R.H.B., Amiri M., Merie C., Lebech A.-M., Katzenstein T., Bang L.E., Kj&#xe6;rgaard J., Kondziella D., Benros M.E. Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for non-COVID-19 illness. JAMA Psychiatry. 2022;79:486&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8943626</ArticleId><ArticleId IdType="pubmed">35319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawal G., Yadav S., Kumar R. Post-intensive care syndrome: an overview. J. Transl. Int. Med. 2017;5:90&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506407</ArticleId><ArticleId IdType="pubmed">28721340</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., Zandi M.S., Lewis G., David A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2013;627. doi: 10.1016/s2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston P., Parmar M.K.B. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat. Med. 2002;21(15):2175&#x2013;2197. doi: 10.1002/sim.1203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1203</ArticleId><ArticleId IdType="pubmed">12210632</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwake L., Wollenschl&#xe4;ger I., Stremmel W., Encke J. Adverse drug reactions and deliberate self-poisoning as cause of admission to the intensive care unit: a 1-year prospective observational cohort study. Intensive Care Med. 2009;35(2):266&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">18696050</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson H.K., Clancy M., Goldfrad C., Rowan K. Admissions to intensive care units from emergency departments: a descriptive study. Emerg. Med. J. 2005;22:423&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1726808</ArticleId><ArticleId IdType="pubmed">15911950</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A.P., Tyrrell D.A.J., Barrow G.I., Higginsaf P.G., Willman J.S., Bull S., Coyle K.B., Trickett S. Mood and experimentally-induced respiratory virus infections and illnesses. Psychol. Health. 1992;6(3):205&#x2013;212.</Citation></Reference><Reference><Citation>Sonneville R., Verdonk F., Rauturier C., Klein I.F., Wolff M., Annane D., Chretien F., Sharshar T. Understanding brain dysfunction in sepsis. Ann. Intensive Care. 2013;3:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3673822</ArticleId><ArticleId IdType="pubmed">23718252</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., Molteni E., Modat M., Jorge Cardoso M., May A., Ganesh S., Davies R., Nguyen L.H., Drew D.A., Astley C.M., Joshi A.D., Merino J., Tsereteli N., Fall T., Gomez M.F., Duncan E.L., Menni C., Williams F.M.K., Franks P.W., Chan A.T., Wolf J., Ourselin S., Spector T., Steves C.J. Attributes and predictors of long COVID. Nat. Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J., Kretzschmar M.E.E. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Harrison P.J. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Sillett R., Zhu L., Mendel J., Camplisson I., Dercon Q., Harrison P.J. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients. The Lancet Psychiatry. 2022;9(10):815&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacas S., Cole D.J., Cannesson M. Cognitive decline associated with anesthesia and surgery in older patients. JAMA. 2021;326(9):863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8807795</ArticleId><ArticleId IdType="pubmed">34338712</ArticleId></ArticleIdList></Reference><Reference><Citation>Vai B., Mazza M.G., Delli Colli C., Foiselle M., Allen B., Benedetti F., Borsini A., Casanova Dias M., Tamouza R., Leboyer M., Benros M.E., Branchi I., Fusar-Poli P., De Picker L.J. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis. Lancet Psychiatry. 2021;8(9):797&#x2013;812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8285121</ArticleId><ArticleId IdType="pubmed">34274033</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser L.H. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur. J. Neurol. 2006;13(11):1203&#x2013;1212.</Citation><ArticleIdList><ArticleId IdType="pubmed">17038033</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson E.J., Walker A.J., Bhaskaran K., Bacon S., Bates C., Morton C.E., Curtis H.J., Mehrkar A., Evans D., Inglesby P., Cockburn J., McDonald H.I., MacKenna B., Tomlinson L., Douglas I.J., Rentsch C.T., Mathur R., Wong A.Y.S., Grieve R., Harrison D., Forbes H., Schultze A., Croker R., Parry J., Hester F., Harper S., Perera R., Evans S.J.W., Smeeth L., Goldacre B. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolkowitz O. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology. 1994;19(3):233&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pubmed">7515507</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. BMJ. 2022;376:e068993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E., Xie Y., Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28(11):2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>